JP2022513459A5 - - Google Patents

Info

Publication number
JP2022513459A5
JP2022513459A5 JP2021533527A JP2021533527A JP2022513459A5 JP 2022513459 A5 JP2022513459 A5 JP 2022513459A5 JP 2021533527 A JP2021533527 A JP 2021533527A JP 2021533527 A JP2021533527 A JP 2021533527A JP 2022513459 A5 JP2022513459 A5 JP 2022513459A5
Authority
JP
Japan
Prior art keywords
nucleic acid
sequence
orf1
acid sequence
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2021533527A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022513459A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/065963 external-priority patent/WO2020123795A2/en
Publication of JP2022513459A publication Critical patent/JP2022513459A/ja
Publication of JP2022513459A5 publication Critical patent/JP2022513459A5/ja
Priority to JP2024075364A priority Critical patent/JP2024099833A/ja
Withdrawn legal-status Critical Current

Links

JP2021533527A 2018-12-12 2019-12-12 タンパク質代替治療モダリティを送達するためのアネロソーム Withdrawn JP2022513459A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024075364A JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862778861P 2018-12-12 2018-12-12
US201862778866P 2018-12-12 2018-12-12
US62/778,861 2018-12-12
US62/778,866 2018-12-12
PCT/US2019/065963 WO2020123795A2 (en) 2018-12-12 2019-12-12 Anellosomes for delivering protein replacement therapeutic modalities

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024075364A Division JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Publications (2)

Publication Number Publication Date
JP2022513459A JP2022513459A (ja) 2022-02-08
JP2022513459A5 true JP2022513459A5 (https=) 2022-12-20

Family

ID=69160356

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021533527A Withdrawn JP2022513459A (ja) 2018-12-12 2019-12-12 タンパク質代替治療モダリティを送達するためのアネロソーム
JP2024075364A Pending JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024075364A Pending JP2024099833A (ja) 2018-12-12 2024-05-07 タンパク質代替治療モダリティを送達するためのアネロソーム

Country Status (11)

Country Link
US (1) US20220073950A1 (https=)
EP (1) EP3894569A2 (https=)
JP (2) JP2022513459A (https=)
KR (1) KR20210125990A (https=)
CN (1) CN114127303A (https=)
AU (1) AU2019395418A1 (https=)
BR (1) BR112021010925A2 (https=)
CA (1) CA3119814A1 (https=)
IL (1) IL283781A (https=)
MX (1) MX2021006945A (https=)
WO (1) WO2020123795A2 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3615659A4 (en) 2017-04-28 2021-01-06 Agrospheres, Inc. COMPOSITIONS AND METHODS OF ENCAPSULATION AND SCALABLE DELIVERY OF AGROCHEMICALS
WO2018201160A1 (en) 2017-04-28 2018-11-01 Agrospheres, Inc. Compositions and methods for enzyme immobilization
CA3073449A1 (en) 2017-09-25 2019-03-28 Agrospheres, Inc. Compositions and methods for scalable production and delivery of biologicals
MX2021006977A (es) * 2018-12-12 2021-10-13 Flagship Pioneering Innovations V Inc Anellosomas y metodos de uso.
AU2021288320A1 (en) * 2020-06-12 2023-01-19 Flagship Pioneering Innovations V, Inc. Tandem anellovirus constructs
MX2022016475A (es) * 2020-06-17 2023-04-11 Flagship Pioneering Innovations V Inc Metodos de identificacion y caracterizacion de anellovirus y usos de los mismos.
TW202235622A (zh) * 2020-12-23 2022-09-16 美商旗艦先鋒創新公司 包裹rna之指環病毒(anellovirus)蛋白殼之活體外組裝
IL311987A (en) * 2021-10-12 2024-06-01 Flagship Pioneering Innovations V Inc New analvector compositions and methods
WO2023069948A1 (en) 2021-10-18 2023-04-27 Flagship Pioneering Innovations Vii, Llc Dna compositions and related methods
TW202529819A (zh) 2023-10-13 2025-08-01 美商旗艦先鋒創新公司 組織特異性指環載體(anellovector)遞送

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL9002008A (nl) * 1990-09-12 1992-04-01 Stichting Centr Diergeneeskund Recombinant dna en rna en daarvan afgeleide produkten.
US6395472B1 (en) * 1999-02-05 2002-05-28 Abbott Laboratories Methods of utilizing the TT virus
US9676828B2 (en) * 2010-06-23 2017-06-13 Deutsches Krebsforschungszentrum Rearranged TT virus molecules for use in diagnosis, prevention and treatment of cancer and autoimmunity
IL271275B1 (en) * 2017-06-13 2026-04-01 Flagship Pioneering Innovations V Inc Preparations containing croons and their uses
AU2019396520A1 (en) * 2018-12-12 2021-05-27 Flagship Pioneering Innovations V, Inc. Anellosomes for delivering secreted therapeutic modalities
MX2021006977A (es) * 2018-12-12 2021-10-13 Flagship Pioneering Innovations V Inc Anellosomas y metodos de uso.
CN114127302A (zh) * 2018-12-12 2022-03-01 旗舰先锋创新V股份有限公司 用于递送细胞内治疗方式的指环体

Similar Documents

Publication Publication Date Title
JP2022513459A5 (https=)
JP2022512395A5 (https=)
JP2022513797A5 (https=)
KR101817482B1 (ko) 캄필로박터 제주니 crispr/cas 시스템 유래 rgen을 이용한 유전체 교정
CN114736901B (zh) 用于减少pd-l1表达的寡核苷酸
US20260009050A1 (en) Anellosomes for delivering secreted therapeutic modalities
JP2022514501A5 (https=)
JP2019508364A (ja) 免疫抑制療法中のjcウイルス活性化およびpml(進行性多巣性白質脳症)のリスクを除去するための遺伝子編集方法および組成物
JP2024533312A5 (https=)
CN110393791B (zh) hnRNPA2B1的抗感染作用及其应用
CA3119814A1 (en) Anellosomes for delivering protein replacement therapeutic modalities
KR20210131310A (ko) 아넬로좀 및 사용 방법
US20250011766A1 (en) Genome Editing Compositions and Methods for Treatment of Amyotrophic Lateral Sclerosis
CA3119339A1 (en) Anellosomes for delivering intracellular therapeutic modalities
TW202223095A (zh) 串聯指環病毒構築體
KR20250053925A (ko) CRISPR-Cas13 시스템 및 이의 용도
Su et al. Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization
JP2024543994A (ja) 硝子体内投与用の機能性aavカプシド
JP2018148865A (ja) ボルナウイルスベクター及びその利用
CA2251818A1 (en) Mammalian genes involved in viral infection and tumor suppression
KR20230124682A (ko) Rna를 봉입하는 아넬로바이러스 캡시드의 시험관 내어셈블리
CN114213505A (zh) 一种适用于特异感染u87-mg细胞的腺相关病毒突变体
US20260071211A1 (en) Genome Editing Compositions and Methods for Treatment of Friedreich's Ataxia
WO2025045079A1 (zh) 一种基于rna特异性脱氨酶突变体及其应用
KR20260007637A (ko) 원형 rna 및 이의 제조방법